GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Omid Holdings Inc (OTCPK:OMID) » Definitions » Revenue per Share

Omid Holdings (Omid Holdings) Revenue per Share : $ (TTM As of . 20)


View and export this data going back to . Start your Free Trial

What is Omid Holdings Revenue per Share?

Omid Holdings's revenue per share for the three months ended in . 20 was $0.00. Omid Holdings does not have enough years/quarters to calculate the revenue per share for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Omid Holdings's Revenue per Share or its related term are showing as below:

OMID's 3-Year Revenue Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.45
* Ranked among companies with meaningful 3-Year Revenue Growth Rate only.

Omid Holdings Revenue per Share Historical Data

The historical data trend for Omid Holdings's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omid Holdings Revenue per Share Chart

Omid Holdings Annual Data
Trend
Revenue per Share

Omid Holdings Quarterly Data
Revenue per Share

Competitive Comparison of Omid Holdings's Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Omid Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omid Holdings's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Omid Holdings's PS Ratio distribution charts can be found below:

* The bar in red indicates where Omid Holdings's PS Ratio falls into.



Omid Holdings Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Omid Holdings's Revenue Per Share for the fiscal year that ended in . 20 is calculated as

Revenue Per Share (A: . 20 )=Revenue (A: . 20 )/Shares Outstanding (Diluted Average) (A: . 20 )
=/0
=

Omid Holdings's Revenue Per Share for the quarter that ended in . 20 is calculated as

Revenue Per Share (Q: . 20 )=Revenue (Q: . 20 )/Shares Outstanding (Diluted Average) (Q: . 20 )
=/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Omid Holdings  (OTCPK:OMID) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Omid Holdings Revenue per Share Related Terms

Thank you for viewing the detailed overview of Omid Holdings's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Omid Holdings (Omid Holdings) Business Description

Traded in Other Exchanges
N/A
Address
1130 Springtown Road, Suite B, Phillipsburg, NJ, USA, 08865
Omid Holdings Inc is a health and wellness company. It is specialized in the sale and manufacture of CBD-based products. The company manufactures and sells branded inhalable, sublingual, and topical hemp-derived consumer goods. Its brands include Naturally Peaked Health, Shangri-La Life, and Peac Wellness. The company also offers design, development, manufacturing services to clients in the CBD-based cannabis industry.

Omid Holdings (Omid Holdings) Headlines

From GuruFocus

OMID Provides Third-Quarter Financial Highlights

By PRNewswire PRNewswire 10-12-2021

OMID Holdings Completes Share Cancellation

By PRNewswire PRNewswire 01-27-2021

OMID Reports Strong Second-Quarter Financial Results

By PRNewswire PRNewswire 09-16-2020

OMID Announces Reduction of Common Shares

By PRNewswire PRNewswire 06-24-2021

OMID Makes Strategic Investment Into Psychedelic Medicine

By PRNewswire PRNewswire 08-12-2021

OMID Provides Fourth-Quarter Financial Highlights

By PRNewswire PRNewswire 01-14-2021

OMID Launches New Products and Marketing

By PRNewswire PRNewswire 06-16-2020

OMID Posts Third Quarter Financial Statements

By PRNewswire PRNewswire 11-09-2021

AV1 Group, Inc. Announces LOI

By Marketwired Marketwired 05-08-2019

OMID Holdings, Inc. Issues Shareholder Letter

By PRNewswire PRNewswire 03-02-2021